Logo image of VXX

IPATH SERIES B S&P 500 VIX (VXX) Stock Price, Forecast & Analysis

USA - NYSE Arca - NYSEARCA:VXX - US06748M1962 - ETF

37.32 USD
-2.16 (-5.47%)
Last: 11/21/2025, 10:04:10 PM
37.25 USD
-0.07 (-0.19%)
After Hours: 11/21/2025, 10:04:10 PM
Fundamental Rating

3

VXX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 387 industry peers in the Banks industry. Both the profitability and financial health of VXX have multiple concerns. VXX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year VXX was profitable.
In the past year VXX has reported a negative cash flow from operations.
In the past 5 years VXX has always been profitable.
Of the past 5 years VXX 4 years had a positive operating cash flow.
VXX Yearly Net Income VS EBIT VS OCF VS FCFVXX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

1.2 Ratios

VXX has a worse Return On Assets (0.59%) than 73.01% of its industry peers.
The Return On Equity of VXX (12.49%) is better than 83.03% of its industry peers.
Industry RankSector Rank
ROA 0.59%
ROE 12.49%
ROIC N/A
ROA(3y)0.32%
ROA(5y)0.31%
ROE(3y)6.92%
ROE(5y)6.41%
ROIC(3y)N/A
ROIC(5y)N/A
VXX Yearly ROA, ROE, ROICVXX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

1.3 Margins

VXX's Profit Margin of 20.33% is on the low side compared to the rest of the industry. VXX is outperformed by 64.52% of its industry peers.
VXX's Profit Margin has improved in the last couple of years.
VXX does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 20.33%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.91%
PM growth 5Y11.07%
GM growth 3YN/A
GM growth 5YN/A
VXX Yearly Profit, Operating, Gross MarginsVXX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1

2. Health

2.1 Basic Checks

VXX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VXX has less shares outstanding
The number of shares outstanding for VXX has been reduced compared to 5 years ago.
The debt/assets ratio for VXX has remained at the same level compared to a year ago.
VXX Yearly Shares OutstandingVXX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
VXX Yearly Total Debt VS Total AssetsVXX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T

2.2 Solvency

A Debt/Equity ratio of 3.86 is on the high side and indicates that VXX has dependencies on debt financing.
The Debt to Equity ratio of VXX (3.86) is worse than 94.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.86
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.24%
VXX Yearly LT Debt VS Equity VS FCFVXX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
VXX Yearly Current Assets VS Current LiabilitesVXX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

5

3. Growth

3.1 Past

VXX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.69%, which is quite impressive.
The Earnings Per Share has been growing by 11.00% on average over the past years. This is quite good.
Looking at the last year, VXX shows a small growth in Revenue. The Revenue has grown by 5.48% in the last year.
The Revenue has been growing slightly by 5.03% on average over the past years.
EPS 1Y (TTM)36.69%
EPS 3Y0.56%
EPS 5Y11%
EPS Q2Q%12.77%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y7.82%
Revenue growth 5Y5.03%
Sales Q2Q%9.47%

3.2 Future

VXX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.26% yearly.
VXX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.43% yearly.
EPS Next Y11.19%
EPS Next 2Y16.98%
EPS Next 3Y16.38%
EPS Next 5Y10.26%
Revenue Next Year9.43%
Revenue Next 2Y7.17%
Revenue Next 3Y6.06%
Revenue Next 5Y4.43%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
VXX Yearly Revenue VS EstimatesVXX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
VXX Yearly EPS VS EstimatesVXX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

VXX is valuated correctly with a Price/Earnings ratio of 15.17.
70.69% of the companies in the same industry are cheaper than VXX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of VXX to the average of the S&P500 Index (25.47), we can say VXX is valued slightly cheaper.
A Price/Forward Earnings ratio of 13.27 indicates a correct valuation of VXX.
Based on the Price/Forward Earnings ratio, VXX is valued a bit more expensive than 70.95% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.42. VXX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 15.17
Fwd PE 13.27
VXX Price Earnings VS Forward Price EarningsVXX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VXX Per share dataVXX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as VXX's earnings are expected to grow with 16.38% in the coming years.
PEG (NY)1.36
PEG (5Y)1.38
EPS Next 2Y16.98%
EPS Next 3Y16.38%

3

5. Dividend

5.1 Amount

VXX has a Yearly Dividend Yield of 2.14%. Purely for dividend investing, there may be better candidates out there.
VXX's Dividend Yield is slightly below the industry average, which is at 3.33.
Compared to an average S&P500 Dividend Yield of 2.41, VXX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.14%

5.2 History

The dividend of VXX is nicely growing with an annual growth rate of 6.61%!
VXX does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)6.61%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

VXX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2Y16.98%
EPS Next 3Y16.38%
VXX Yearly Income VS Free CF VS DividendVXX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B

IPATH SERIES B S&P 500 VIX

NYSEARCA:VXX (11/21/2025, 10:04:10 PM)

After market: 37.25 -0.07 (-0.19%)

37.32

-2.16 (-5.47%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-22 2025-10-22/bmo
Earnings (Next)02-10 2026-02-10/amc
Inst Owners55.08%
Inst Owner Change-8.8%
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap129.89B
Revenue(TTM)47.27B
Net Income(TTM)9.48B
Analysts80
Price Target38.7 (3.7%)
Short Float %0.22%
Short Ratio0.89
Dividend
Industry RankSector Rank
Dividend Yield 2.14%
Yearly Dividend0.81
Dividend Growth(5Y)6.61%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.23%
Min EPS beat(2)13.75%
Max EPS beat(2)16.7%
EPS beat(4)4
Avg EPS beat(4)29.84%
Min EPS beat(4)13.75%
Max EPS beat(4)64.16%
EPS beat(8)8
Avg EPS beat(8)28.97%
EPS beat(12)12
Avg EPS beat(12)22.72%
EPS beat(16)16
Avg EPS beat(16)27.45%
Revenue beat(2)2
Avg Revenue beat(2)2.74%
Min Revenue beat(2)1.38%
Max Revenue beat(2)4.11%
Revenue beat(4)4
Avg Revenue beat(4)2.75%
Min Revenue beat(4)1.38%
Max Revenue beat(4)4.11%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.17%
PT rev (3m)-9.85%
EPS NQ rev (1m)-4.76%
EPS NQ rev (3m)-9.53%
EPS NY rev (1m)2.44%
EPS NY rev (3m)-1.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.78%
Revenue NY rev (1m)0.75%
Revenue NY rev (3m)0.94%
Valuation
Industry RankSector Rank
PE 15.17
Fwd PE 13.27
P/S 2.13
P/FCF N/A
P/OCF N/A
P/B 1.31
P/tB 1.47
EV/EBITDA N/A
EPS(TTM)2.46
EY6.59%
EPS(NY)2.81
Fwd EY7.54%
FCF(TTM)-3.82
FCFYN/A
OCF(TTM)-3.82
OCFYN/A
SpS17.53
BVpS28.54
TBVpS25.46
PEG (NY)1.36
PEG (5Y)1.38
Graham Number39.75
Profitability
Industry RankSector Rank
ROA 0.59%
ROE 12.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 20.33%
GM N/A
FCFM N/A
ROA(3y)0.32%
ROA(5y)0.31%
ROE(3y)6.92%
ROE(5y)6.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.91%
PM growth 5Y11.07%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 3.86
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC6.24%
ROIC/WACCN/A
Cap/Depr(3y)89.52%
Cap/Depr(5y)85.55%
Cap/Sales(3y)5.72%
Cap/Sales(5y)5.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.69%
EPS 3Y0.56%
EPS 5Y11%
EPS Q2Q%12.77%
EPS Next Y11.19%
EPS Next 2Y16.98%
EPS Next 3Y16.38%
EPS Next 5Y10.26%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y7.82%
Revenue growth 5Y5.03%
Sales Q2Q%9.47%
Revenue Next Year9.43%
Revenue Next 2Y7.17%
Revenue Next 3Y6.06%
Revenue Next 5Y4.43%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.18%
FCF growth 3Y-51.04%
FCF growth 5YN/A
OCF growth 1Y-25.18%
OCF growth 3Y-47.42%
OCF growth 5YN/A

IPATH SERIES B S&P 500 VIX / VXX FAQ

What does VXX do?

Barclays PLC is a bank holding company, which engages in the provision of retail banking, credit cards, corporate and investment banking, and wealth management services. The Barclays UK division represents businesses that sit within the United Kingdom ring-fenced bank, Barclays Bank UK PLC and its subsidiaries, and comprises Personal Banking, UK Business Banking and Barclaycard Consumer UK. The Barclays UK Corporate Bank division offers lending, trade and working capital, liquidity, payments, and FX solutions for corporate clients. Barclays Private Bank and Wealth Management division comprises the Private Bank, Wealth Management, and Investments businesses. Barclays Investment Bank division incorporates the Global Markets, Investment Banking, and International Corporate Banking businesses. Barclays US Consumer Bank division represents the United States credit card business, focused on the partnership market, as well as an online deposit franchise.


Can you provide the latest stock price for IPATH SERIES B S&P 500 VIX?

The current stock price of VXX is 37.32 USD. The price decreased by -5.47% in the last trading session.


What is the ChartMill technical and fundamental rating of VXX stock?

VXX has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Is IPATH SERIES B S&P 500 VIX (VXX) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on VXX.